93 related articles for article (PubMed ID: 24703201)
1. Identification of novel inhibitors of Daboia russelli phospholipase A2 using the combined pharmacophore modeling approach.
Ramakrishnan C; Joshi V; Joseph JM; Vishwanath BS; Velmurugan D
Chem Biol Drug Des; 2014 Oct; 84(4):379-92. PubMed ID: 24703201
[TBL] [Abstract][Full Text] [Related]
2. Virtual analysis of structurally diverse synthetic analogs as inhibitors of snake venom secretory phospholipase A2.
Sivaramakrishnan V; Ilamathi M; Ghosh KS; Sathish S; Gowda TV; Vishwanath BS; Rangappa KS; Dhananjaya BL
J Mol Recognit; 2016 Jan; 29(1):22-32. PubMed ID: 26218369
[TBL] [Abstract][Full Text] [Related]
3. Structures and binding studies of the complexes of phospholipase A2 with five inhibitors.
Shukla PK; Gautam L; Sinha M; Kaur P; Sharma S; Singh TP
Biochim Biophys Acta; 2015 Apr; 1854(4):269-77. PubMed ID: 25541253
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics simulations reveal structural insights into inhibitor binding modes and functionality in human Group IIA phospholipase A
Kim RR; Malde AK; Nematollahi A; Scott KF; Church WB
Proteins; 2017 May; 85(5):827-842. PubMed ID: 28056488
[TBL] [Abstract][Full Text] [Related]
5. High-affinity selective inhibitor against phospholipase A2 (PLA2): a computational study.
Chinnasamy S; Chinnasamy S; Muthusamy K
J Recept Signal Transduct Res; 2016; 36(2):111-8. PubMed ID: 26422703
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous inhibition of anti-coagulation and inflammation: crystal structure of phospholipase A2 complexed with indomethacin at 1.4 A resolution reveals the presence of the new common ligand-binding site.
Singh N; Kumar RP; Kumar S; Sharma S; Mir R; Kaur P; Srinivasan A; Singh TP
J Mol Recognit; 2009; 22(6):437-45. PubMed ID: 19462410
[TBL] [Abstract][Full Text] [Related]
7. Computational and in vitro insights on snake venom phospholipase A
Muthusamy K; Chinnasamy S; Nagarajan S; Sivaraman T
J Biomol Struct Dyn; 2018 Dec; 36(16):4197-4208. PubMed ID: 29171346
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of the complexes of a group IIA phospholipase A2 with two natural anti-inflammatory agents, anisic acid, and atropine reveal a similar mode of binding.
Singh N; Jabeen T; Pal A; Sharma S; Perbandt M; Betzel C; Singh TP
Proteins; 2006 Jul; 64(1):89-100. PubMed ID: 16596639
[TBL] [Abstract][Full Text] [Related]
9. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2).
Chinnasamy S; Selvaraj G; Selvaraj C; Kaushik AC; Kaliamurthi S; Khan A; Singh SK; Wei DQ
Int J Biol Macromol; 2020 Feb; 144():53-66. PubMed ID: 31838071
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics study of secretory phospholipase A2 of Russell's viper and bovine pancreatic sources.
Ramakrishnan C; Subramanian V; Velmurugan D
J Phys Chem B; 2010 Oct; 114(42):13463-72. PubMed ID: 20923223
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel pyrazole series of group X secreted phospholipase A2 inhibitor (sPLA2X) via fragment based virtual screening.
Chen H; Knerr L; Åkerud T; Hallberg K; Öster L; Rohman M; Österlund K; Beisel HG; Olsson T; Brengdhal J; Sandmark J; Bodin C
Bioorg Med Chem Lett; 2014 Nov; 24(22):5251-5. PubMed ID: 25316315
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of bioactive compounds of Clematis gouriana Roxb. ex DC against snake venom phospholipase A
Muthusamy K; Chinnasamy S; Nagarajan S; Sivaraman T; Chinnasamy S
J Biomol Struct Dyn; 2017 Jul; 35(9):1936-1949. PubMed ID: 27355444
[TBL] [Abstract][Full Text] [Related]
13. Structural Insight into Binding Mode of 9-Hydroxy Aristolochic Acid, Diclofenac and Indomethacin to PLA
Ebrahimi M; Firuzi O; Miri R; Razzaghi-Asl N; Ebadi A
Interdiscip Sci; 2018 Jun; 10(2):400-410. PubMed ID: 27878455
[TBL] [Abstract][Full Text] [Related]
14. In Silico and In Vitro Study of the Bromelain-Phytochemical Complex Inhibition of Phospholipase A2 (Pla2).
Mohamed Tap F; Abd Majid FA; Ismail HF; Wong TS; Shameli K; Miyake M; Ahmad Khairudin NB
Molecules; 2018 Jan; 23(1):. PubMed ID: 29351216
[TBL] [Abstract][Full Text] [Related]
15. β-keto amyrin isolated from Cryptostegia grandiflora R. br. inhibits inflammation caused by Daboia russellii viper venom: Direct binding of β-keto amyrin to phospholipase A
Santhosh KH; Krishna V; Kemparaju K; Manjunatha H; Shashi Kumar R; Mukherjee A; Gomez Mejiba SE; Ramirez DC; Ravindranath BS
Toxicon; 2024 Apr; 241():107679. PubMed ID: 38447765
[TBL] [Abstract][Full Text] [Related]
16. Differential mode of attack on membrane phospholipids by an acidic phospholipase A₂ (RVVA-PLA₂-I) from Daboia russelli venom.
Saikia D; Bordoloi NK; Chattopadhyay P; Choklingam S; Ghosh SS; Mukherjee AK
Biochim Biophys Acta; 2012 Dec; 1818(12):3149-57. PubMed ID: 22921758
[TBL] [Abstract][Full Text] [Related]
17. The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A2.
Pereañez JA; Patiño AC; Núñez V; Osorio E
Chem Biol Interact; 2014 Sep; 220():94-101. PubMed ID: 24995575
[TBL] [Abstract][Full Text] [Related]
18. Structure-based grafting, mutation, and optimization of peptide inhibitors to fit in the active pocket of human secreted phospholipase A2: find new use of old Peptide agents with anti-inflammatory activity.
Zhan C; Li S; Zhong Q; Zhou D
Chem Biol Drug Des; 2015 Apr; 85(4):418-26. PubMed ID: 25187416
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking studies of curcumin analogs with phospholipase A2.
Dileep KV; Tintu I; Sadasivan C
Interdiscip Sci; 2011 Sep; 3(3):189-97. PubMed ID: 21956741
[TBL] [Abstract][Full Text] [Related]
20. Regulation of catalytic function by molecular association: structure of phospholipase A2 from Daboia russelli pulchella (DPLA2) at 1.9 A resolution.
Chandra V; Kaur P; Jasti J; Betzel C; Singh TP
Acta Crystallogr D Biol Crystallogr; 2001 Dec; 57(Pt 12):1793-8. PubMed ID: 11717491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
